uracil has been researched along with 2019 Novel Coronavirus Disease in 8 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| " We compared the antibody titers of SARS-CoV-2 vaccines and the adverse events between patients who received adjuvant UFT and patients who did not." | 1.91 | Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy. ( Doi, T; Funakoshi, Y; Hojo, W; Hokka, D; Maniwa, Y; Minami, H; Mitsui, S; Nishikubo, M; Ohji, G; Sakai, H; Tanaka, Y; Yakushijin, K, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Chen, XY | 1 |
| Yang, L | 1 |
| Yao, Q | 1 |
| Chen, KP | 1 |
| Chistov, AA | 1 |
| Chumakov, SP | 1 |
| Mikhnovets, IE | 1 |
| Nikitin, TD | 1 |
| Slesarchuk, NA | 1 |
| Uvarova, VI | 1 |
| Rubekina, AA | 1 |
| Nikolaeva, YV | 1 |
| Radchenko, EV | 1 |
| Khvatov, EV | 1 |
| Orlov, AA | 1 |
| Frolenko, VS | 1 |
| Sukhorukov, MV | 1 |
| Kolpakova, ES | 1 |
| Shustova, EY | 1 |
| Galochkina, AV | 1 |
| Streshnev, PP | 1 |
| Osipov, EM | 1 |
| Sapozhnikova, KA | 1 |
| Moiseenko, AV | 1 |
| Brylev, VA | 1 |
| Proskurin, GV | 1 |
| Dokukin, YS | 1 |
| Kutyakov, SV | 1 |
| Aralov, AV | 1 |
| Korshun, VA | 1 |
| Strelkov, SV | 1 |
| Palyulin, VA | 1 |
| Ishmukhametov, AA | 1 |
| Shirshin, EA | 1 |
| Osolodkin, DI | 1 |
| Shtro, AA | 1 |
| Kozlovskaya, LI | 1 |
| Alferova, VA | 1 |
| Ustinov, AV | 1 |
| Nishikubo, M | 1 |
| Tanaka, Y | 1 |
| Mitsui, S | 1 |
| Doi, T | 1 |
| Hokka, D | 1 |
| Hojo, W | 1 |
| Sakai, H | 1 |
| Funakoshi, Y | 1 |
| Yakushijin, K | 1 |
| Ohji, G | 1 |
| Minami, H | 1 |
| Maniwa, Y | 1 |
| Biteau, NG | 1 |
| Amichai, SA | 1 |
| Azadi, N | 1 |
| De, R | 1 |
| Downs-Bowen, J | 1 |
| Lecher, JC | 1 |
| MacBrayer, T | 1 |
| Schinazi, RF | 1 |
| Amblard, F | 1 |
| Rice, AM | 1 |
| Castillo Morales, A | 1 |
| Ho, AT | 1 |
| Mordstein, C | 1 |
| Mühlhausen, S | 1 |
| Watson, S | 1 |
| Cano, L | 1 |
| Young, B | 1 |
| Kudla, G | 1 |
| Hurst, LD | 1 |
| Kosuge, M | 1 |
| Furusawa-Nishii, E | 1 |
| Ito, K | 1 |
| Saito, Y | 1 |
| Ogasawara, K | 1 |
| Ou, Z | 1 |
| Ouzounis, C | 1 |
| Wang, D | 1 |
| Sun, W | 1 |
| Li, J | 1 |
| Chen, W | 1 |
| Marlière, P | 1 |
| Danchin, A | 1 |
1 review available for uracil and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
1 trial available for uracil and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
7 other studies available for uracil and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Human SARS-CoV-2 has evolved to increase U content and reduce genome size.
Topics: Base Composition; Base Sequence; China; Codon; COVID-19; Evolution, Molecular; Genome; Genome Size; | 2022 |
5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro.
Topics: Antiviral Agents; COVID-19; Humans; Perylene; SARS-CoV-2; Uracil | 2023 |
Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2023 |
Synthesis of 4'-Substituted Carbocyclic Uracil Derivatives and Their Monophosphate Prodrugs as Potential Antiviral Agents.
Topics: Antiviral Agents; COVID-19; Hepatitis C Antibodies; Humans; Influenza A virus; Influenza B virus; Nu | 2023 |
Evidence for Strong Mutation Bias toward, and Selection against, U Content in SARS-CoV-2: Implications for Vaccine Design.
Topics: COVID-19; COVID-19 Vaccines; Genome, Viral; Humans; Mutation; RNA Stability; RNA, Messenger; RNA, Vi | 2021 |
Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.
Topics: Adenosine Deaminase; APOBEC Deaminases; Betacoronavirus; Cell Line, Tumor; Coronavirus Infections; C | 2020 |
A Path toward SARS-CoV-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution.
Topics: COVID-19; Cytidine Triphosphate; Cytosine; Evolution, Molecular; Genome, Viral; Host-Pathogen Intera | 2020 |